IP Library Granted Patent US 9,138,515
Granted Patent B2
US 9,138,515 · App. 13/780,438 · Granted Sep 22, 2015

System and method for managing reduced pressure at a tissue site

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,138,515
App. No.
13/780,438
Granted
Sep 22, 2015
Kind
B2
Abstract

The illustrative embodiments described herein are directed to an apparatus and method for managing reduced pressure at a tissue site. The apparatus includes a reduced pressure source that generates reduced pressure. The reduced pressure is delivered to the tissue site via a delivery tube. The apparatus includes a single pressure sensor. The single pressure sensor detects an actual reduced pressure at the tissue site. The apparatus also includes a controller. The controller determines a responsiveness of the actual reduced pressure measured by the single pressure sensor to an increase in reduced pressure generated by the reduced pressure source. The apparatus includes an indicator. The indicator emits a signal when the controller determines that the actual reduced pressure measured by the single pressure sensor is nonresponsive to the increase in reduced pressure generated by the reduced pressure source.

Claims (18)

1. A method for managing reduced pressure at a tissue site, the method comprising:

detecting a change to an operating parameter of a reduced pressure source indicative of a change to reduced pressure generated by the reduced pressure source;

determining an actual reduced pressure at the tissue site using a single pressure sensor; and

responsive to the actual reduced pressure at the tissue site being nonresponsive to the change to the operating parameter, emitting a signal using an indicator.

2. The method of claim 1 , wherein the actual reduced pressure at the tissue site is nonresponsive to increasing the generated reduced pressure when the actual reduced pressure at the tissue site fails to increase within a predefined time period in response to increasing the generated reduced pressure.

3. The method of claim 1 , wherein the actual reduced pressure at the tissue site is nonresponsive to increasing the generated reduced pressure when the actual reduced pressure at the tissue site fails to meet a target reduced pressure within a predefined time period in response to increasing the generated reduced pressure.

4. The method of claim 1 , further comprising:

determining a target reduced pressure for the tissue site; and

comparing the actual reduced pressure detected by the single pressure sensor with the target reduced pressure.

5. The method of claim 4 , further comprising:

responsive to the actual reduced pressure exceeding the target reduced pressure, decreasing the generated reduced pressure generated by the reduced pressure source.

6. The method of claim 1 , wherein the responsiveness is determined by monitoring whether the actual reduced pressure at the tissue site changes within a predefined period of time.

7. The method of claim 1 , wherein the responsiveness is determined by monitoring whether the actual reduced pressure at the tissue site meets a target reduced pressure within a predefined period of time.

8. The method of claim 1 , wherein the operating parameter is a current draw by a motor associated with the reduced pressure source.

9. The method of claim 1 , wherein the operating parameter is a speed of a motor associated with the reduced pressure source.

10. The method of claim 1 , wherein the operating parameter is a speed of a chemical reaction associated with the reduced pressure source.

11. The method of claim 1 , wherein the responsiveness is determined by monitoring whether the actual reduced pressure at the tissue site changes within a range of 1 to 10 seconds.

12. The method of claim 1 , wherein the responsiveness is determined by monitoring whether the actual reduced pressure at the tissue site changes within a range of 4 to 6 seconds.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2013
From: LOCKE, CHRISTOPHER BRIAN; BEARD, MARK STEPHEN JAMES
To: KCI LICENSING, INC.
Reel/Frame 030846/0035 →